Content about Forest Labs

May 23, 2013
Forest Labs to find new president, CEO before year's end

Forest Labs president and CEO Howard Solomon will retire at the end of 2013, the company said.

April 17, 2013
Sandoz launches generic cardiovascular disease drug

Generic drug maker Sandoz has launched a generic version of a drug used to treat high blood pressure and angina.

February 25, 2013
Generic tsunami eases, but leaves transformed Rx landscape in its wake

The generic drug tidal wave became a tsunami in 2012, with some of the world's top-selling pharmaceuticals swamped by generic competition, and health plan payers scrambling to reap billions of dollars in financial savings.

July 24, 2012
FDA approves new COPD drug

The Food and Drug Administration has approved a new drug made by Forest Labs for treating chronic obstructive pulmonary disease, the agency said.

April 3, 2012
Forest buys rights to Bystolic from J&J

Forest Labs has bought rights to a drug used for high blood pressure that it had marketed with a Johnson & Johnson subsidiary, thus eliminating the need to pay future royalties.

March 29, 2012
FDA extends approval time for COPD drug by three months

Regulators will take a few months longer to review the approval application for a new drug for treating chronic obstructive pulmonary disease, the drug's developers said Thursday.

March 26, 2012
ReportersNotebook — Chain Pharmacy, 4/2/12

A drug under development by Forest Labs and Pierre Fabre has been shown to reduce symptoms of major depressive disorder, the companies said.

March 16, 2012
Amerigen joins Bystolic patent challenge

Another generic drug maker has joined efforts to challenge the patent on a drug made by Forest Labs for treating hypertension.

March 15, 2012
Amneal launches liquid generic Lexapro

Amneal Pharmaceuticals has launched a generic version of an antidepressant made by Forest Labs.

March 14, 2012
FDA approves generic version of Lexapro

The Food and Drug Administration has approved the first generic version of an antidepressant made by Forest Labs, the agency said Wednesday.

March 14, 2012
Forest files suit over generic versions of hypertension drug

Forest Labs has filed suit against Glenmark Generics and several other companies, alleging that they infringed on its patent for a drug to treat hypertension by seeking regulatory approval for generic versions.

March 7, 2012
Forest, Pierre Fabre drug 'significantly' reduced depression symptoms

A drug under development by Forest Labs and Pierre Fabre "significantly" reduced symptoms of major depressive disorder, the companies said Wednesday.

February 29, 2012
Mylan launches generic version of Forest Labs' Lexapro

Mylan has launched a generic drug for treating depression and anxiety, the company said Wednesday.

July 19, 2011
Investigational antidepressant garners positive results in late-stage clinical trial

Patients taking an investigative antidepressant undergoing late-stage clinical development showed “significant” improvement, according to study results released Monday.

June 10, 2011
Forest announces availability of Daliresp

A drug for chronic obstructive pulmonary disease made by Forest Labs will be available by the middle of this month, Forest said Thursday.

April 19, 2011
Forest purchases rights to azimilide

Drug maker Forest Labs has acquired worldwide rights to a drug developed by Procter & Gamble Pharmaceuticals for treating arrhythmia.

March 1, 2011
Forest gets nod for COPD drug

The Food and Drug Administration has approved a treatment for chronic obstructive pulmonary disease made by Forest Labs, the agency said Tuesday.

February 23, 2011
Forest to acquire Clinical Data

Drug maker Forest Labs plans to acquire the developer of a recently approved antidepressant.

January 21, 2011
Forest Labs announces phase-3 trial results for depression drug

A drug for major depressive disorder worked better than placebo, according to results of a late-stage clinical trial announced Thursday.

December 15, 2010
FDA: Tessalon should be packaged in childproof containers

A prescription cough suppressant should be kept in childproof containers because of its candy-like appearance, the Food and Drug Administration warned Tuesday.

October 31, 2010
FDA approves new treatment for bacterial infections

The Food and Drug Administration has approved a new treatment for bacterial infections made by...

September 15, 2010
Forest Pharmaceuticals pays $313 million in settlement deal

Drug maker Forest Pharmaceuticals will pay more than $300 million to the federal government as...

August 10, 2010
Generic unipolar depression drugs may shrink market size

The drug market for unipolar depression will get smaller over the next decade due to...

© 2013 Drug Store News. All Rights Reserved.